Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology

Cited by (363)

Items 101–200 of 363

1. Clinical pet imaging of microglial activation: Implications for microglial therapeutics in alzheimer’s disease
   Shen, Zhiwei, Bao, Xinjie, Wang, Renzhi · 2018 · Frontiers in Aging Neuroscience
2. An “Amyloid‐β Cleaner” for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction
   Ruiyuan Liu, Jun Yang, Linying Liu, Zhiguo Lü, Zhuyan Shi, Weihong Ji, Jie Shen, Xin Zhang · 2019 · Advanced Science
3. Lactate and Lactylation in the Brain: Current Progress and Perspectives
   Ruobing Li, Yi Yang, Haoyu Wang, Tingting Zhang, Fangfang Duan, Kaidi Wu, Siyu Yang, Ke Xu, Xicheng Jiang, Xiaowei Sun · 2023 · Cellular and Molecular Neurobiology
4. Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype
   Minter, Myles R., Moore, Zachery, Zhang, Moses, Brody, Kate M., Jones, Nigel C., Shultz, Sandy R., Taylor, Juliet M., Crack, Peter J. · 2016 · Acta Neuropathologica Communications
5. Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain
   Zejie Zuo, Fangfang Qi, Junhua Yang, Xiao Wang, Yingying Wu, Yaru Wen, Qunfang Yuan, Juntao Zou, Kaihua Guo, Zhi Bin Yao · 2017 · Neurobiology of Disease
6. Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype
   Jacob S. Friedberg, Nurgül Aytan, Jonathan D. Cherry, Weiming Xia, Oliver J. Standring, Victor E. Alvarez, Raymond Nicks, Sarah E. Svirsky, Gaoyuan Meng, Gyungah Jun et al. · 2020 · Scientific Reports
7. Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming
   Sun, Zhao, Kwon, Ji-Sun, Ren, Yudong, Chen, Shawei, Walker, Courtney K., Lu, Xinguo, Cates, Kitra, Karahan, Hande, Sviben, Sanja, Fitzpatrick, James A. J. et al. · 2024 · Science
8. Protective and Regenerative Roles of T Cells in Central Nervous System Disorders
   Frances Evans, Marie Dittmer, Alerie Guzman de la Fuente, Denise C. Fitzgerald · 2019 · Frontiers in Immunology
9. Intraperitoneal injection of IFN-γ restores microglial autophagy, promotes amyloid-β clearance and improves cognition in APP/PS1 mice
   Zitian He, Yunjie Yang, Zhiwei Xing, Zejie Zuo, Rui Wang, Huaiyu Gu, Fangfang Qi, Zhibin Yao · 2020 · Cell Death and Disease
10. Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer’s disease: a meta-analytic review on potential mechanisms
    Chuan Qin, Yalan Lu, Kewei Wang, Lin Bai, Guiying Shi, Yiying Huang, Yongning Li · 2020 · Translational Neurodegeneration
11. IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia
    Rivera-Escalera, Fátima, Pinney, Jonathan J., Owlett, Laura, Ahmed, Hoda, Thakar, Juilee, Olschowka, John A., Elliott, Michael R., O’Banion, M. Kerry · 2019 · Journal of Neuroinflammation
12. Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
    Weston, Lea L., Jiang, Shanya, Chisholm, Devon, Jantzie, Lauren L., Bhaskar, Kiran · 2021 · Journal of Neuroinflammation
13. Innate immune activation in Alzheimer’s disease
    Mingming Wang, Dan Miao, Xi‐Peng Cao, Lin Tan, Lan Tan · 2018 · Annals of Translational Medicine
14. The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets
    AmeliMojarad, Melika, AmeliMojarad, Mandana · 2024 · CNS Neuroscience & Therapeutics
15. Brain interference: Revisiting the role of IFNγ in the central nervous system
    Susana Monteiro, Susana Roque, Fernanda Marques, Margarida Correia‐Neves, João Cerqueira · 2017 · Progress in Neurobiology
16. Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
    Lee‐Way Jin, Jacopo Di Lucente, Hai Minh Nguyen, Vikrant Singh, Latika Singh, Monique Chavez, Trevor R. Bushong, Heike Wulff, Izumi Maezawa · 2019 · Annals of Clinical and Translational Neurology
17. Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease
    Yin, Ping, Wang, Xu, Wang, Shuang, Wei, Yafen, Feng, Jiachun, Zhu, Mingqin · 2019 · Frontiers in Cellular Neuroscience
18. Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies
    Sun, Zhongqing, Zhang, Xin, So, Kwok-Fai, Jiang, Wen, Chiu, Kin · 2024 · Biomolecules
19. CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis
    Nancy Bartolotti, Orly Lazarov · 2019 · Brain Behavior and Immunity
20. Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer’s Disease
    Rashmi Ranjan Das, Subashchandrabose Chinnathambi · 2020 · Neuroscience
21. Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease
    Taoufiq Harach, Fabien Jammes, Charles Muller, N. Duthilleul, V. Cheatham, Valentin Zufferey, David Cheatham, Yelizaveta A. Lukasheva, Theo Lasser, Tristan Bolmont · 2016 · Neurobiology of Aging
22. Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer’s disease-like APPPS1 mice
    Lisa K. Wagner, Kate E. Gilling, Eileen Schormann, Peter Michael Kloetzel, Frank L. Heppner, Elke Krüger, Stefan Prokop · 2017 · Acta Neuropathologica Communications
23. Influenza vaccination in early Alzheimer’s disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells
    Yunjie Yang, Zitian He, Zhiwei Xing, Zejie Zuo, Lifang Yuan, Yingying Wu, Mei Hua Jiang, Fangfang Qi, Zhibin Yao · 2020 · Journal of Neuroinflammation
24. Anti-inflammatory Signaling in Microglia Exacerbates Alzheimer’s Disease-Related Pathology
    Jean-Philippe Michaud, Serge Rivest · 2015 · Neuron
25. A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease
    Michael G. Agadjanyan, Nikolai Petrovsky, Anahit Ghochikyan · 2015 · Alzheimer s & Dementia
26. Activation of STAT3 Regulates Reactive Astrogliosis and Neuronal Death Induced by AβO Neurotoxicity
    Danira Toral-Ríos, Genaro Patiño‐López, Gisela Gómez‐Lira, Rafael Gutiérrez, Fernando Becerril-Pérez, Aldebarán Rosales-Córdova, Juan Carlos León‐Contreras, Rogélio Hernández‐Pando, Ismael León‐Rivera, Isabel Soto‐Cruz et al. · 2020 · International Journal of Molecular Sciences
27. Mapping of Variable DNA Methylation Across Multiple Cell Types Defines a Dynamic Regulatory Landscape of the Human Genome
    Junchen Gu, Michael W. Stevens, Xiaoyun Xing, Daofeng Li, Bo Zhang, Jacqueline E. Payton, Eugene M. Oltz, James N. Jarvis, Kaiyu Jiang, Theodore J. Cicero et al. · 2016 · G3 Genes Genomes Genetics
28. Tryptophan Metabolism in Alzheimer’s Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis
    Lushuang Xie, Qiaofeng Wu, Kelin Li, Mohammed A. S. Khan, Andrew Zhang, Bharati Sinha, Sihui Li, Sulie L. Chang, David L. Brody, Mark W. Grinstaff et al. · 2024 · Aging and Disease
29. AF710B, an M1/sigma‐1 receptor agonist with long‐lasting disease‐modifying properties in a transgenic rat model of Alzheimer's disease
    Hélène Hall, M. Florencia Iulita, Palma Gubert, Lisi Flores Aguilar, Adriana Ducatenzeiler, Abraham Fisher, A. Claudio Cuello · 2017 · Alzheimer s & Dementia
30. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer’s disease pathophysiology
    Cornejo, Francisca, Vruwink, Marianne, Metz, Claudia, Muñoz, Paola, Salgado, Nicole, Poblete, Joaquín, Andrés, María Estela, Eugenín, Jaime, von Bernhardi, Rommy · 2018 · Brain, Behavior, and Immunity
31. 5xFAD Mice Display Sex-Dependent Inflammatory Gene Induction During the Prodromal Stage of Alzheimer’s Disease
    Zahra Manji, Asheebo Rojas, Wenyi Wang, Raymond J Dingledine, Nicholas H. Varvel, Thota Ganesh · 2019 · Journal of Alzheimer s Disease
32. Alzheimer’s disease and cytokine IL-10 gene polymorphisms: is there an association?
    Carolina Antunes Magalhaes, María das Graças Carvalho Ferriani, Lirlandia Pires Sousa, Paulo Caramelli, Karina Braga Gomes · 2017 · Arquivos de Neuro-Psiquiatria
33. Cognitive impairment after long COVID-19: current evidence and perspectives
    Zhitao Li, Zhen Zhang, Zhuoya Zhang, Zhiyong Wang, Hao Li · 2023 · Frontiers in Neurology
34. Advancing combination therapy for Alzheimer's disease
    S. Salloway, Jeff Sevingy, K. Budur, Jan Pederson, R. DeMattos, P. von Rosenstiel, A. Páez, R. Evans, Christopher J. Weber, James A. Hendrix et al. · 2020 · Alzheimer's & Dementia
35. N , N ′-Diacetyl- p -phenylenediamine restores microglial phagocytosis and improves cognitive defects in Alzheimer’s disease transgenic mice
    Min Hee Park, Misun Lee, Geewoo Nam, Mingeun Kim, Juhye Kang, Byung Jo Choi, Min Seock Jeong, Kang Ho Park, Wan Hui Han, Eunyoung Tak et al. · 2019 · Proceedings of the National Academy of Sciences
36. Immunological Features of Non-neuronal Brain Cells: Implications for Alzheimer’s Disease Immunotherapy
    Giulia Castellani, Michal Schwartz · 2020 · Trends in Immunology
37. Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients
    Lucio D’Anna, Samir Abu‐Rumeileh, Martina Fabris, Cinzia Pistis, Antonio Baldi, Nova Sanvilli, Francesco Curcio, Gian Luigi Gigli, Sebastiano D’Anna, Mariarosaria Valente · 2017 · Neurodegenerative Diseases
38. Spinal microglial β‐endorphin signaling mediates IL‐10 and exenatide‐induced inhibition of synaptic plasticity in neuropathic pain
    Le Ma, Shiyu Peng, Jinbao Wei, Mengjing Zhao, Khalil Ali Ahmad, Jinghong Chen, Yong‐Xiang Wang · 2021 · CNS Neuroscience & Therapeutics
39. An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease
    Yuanbing Jiang, Xiaopu Zhou, Hiu Yi Wong, Li Ouyang, Fanny C.F. Ip, Vicky M. N. Chau, Shun‐Fat Lau, Wei Wu, Daniel Y. K. Wong, Heukjin Seo et al. · 2022 · Nature Aging
40. Increased tauopathy drives microglia-mediated clearance of beta-amyloid
    Wesley Chen, Edsel Abud, Stephen T. Yeung, Anita Lakatos, Trevor Nassi, Jane Wang, David L Blum, Luc Buée, Wayne W. Poon, Mathew M. Blurton-Jones · 2016 · Acta Neuropathologica Communications
41. Resistance Exercise Decreases Amyloid Load and Modulates Inflammatory Responses in the APP/PS1 Mouse Model for Alzheimer’s Disease
    Debora Hashiguchi, Henrique Correia Campos, Raphael Wuo‐Silva, Jean Faber, Sérgio Gomes da Silva, Antônio Augusto Coppi Maciel Ribeiro, Ricardo Mário Arida, Beatriz M. Longo · 2020 · Journal of Alzheimer s Disease
42. Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
    Shun‐Fat Lau, Amy K.Y. Fu, Nancy Y. Ip · 2021 · Cellular and Molecular Life Sciences
43. Susceptibility of brain atrophy to TRIB3 in Alzheimer’s disease, evidence from functional prioritization in imaging genetics
    Marco Lorenzi, André Altmann, Boris A. Gutman, Selina Wray, Charles Arber, Derrek P. Hibar, Neda Jahanshad, Jonathan M. Schott, Daniel C. Alexander, Paul M. Thompson et al. · 2018 · Proceedings of the National Academy of Sciences
44. The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease
    Marija Čuljak, Matea Nikolac Perković, Suzana Uzun, Dubravka Švob Štrac, Gordana Nedić Erjavec, Mirjana Babić Leko, Goran Šimić, Lucija Tudor, Marcela Konjevod, Oliver Kozumplik et al. · 2020 · Current Alzheimer Research
45. Neonatal infection leads to increased susceptibility to Aβ oligomer-induced brain inflammation, synapse loss and cognitive impairment in mice
    Paula S. Frost, Fernanda G. Q. Barros‐Aragão, Rachel T. da Silva, Aline M. Venancio, Isadora C. Pereira Matias, Natalia M. Lyra e Silva, Grasielle Clotildes Kincheski, Pedro M. Pimentel‐Coelho, Fernanda G. De Felice, Flávia Carvalho Alcântara Gomes et al. · 2019 · Cell Death and Disease
46. Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment
    Shang Li, Lailiang Qu, Xiaobing Wang, Lingyi Kong · 2021 · Pharmacology & Therapeutics
47. The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models
    Qiu‐Lan Ma, Cansheng Zhu, Marco Morselli, Trent Su, Matteo Pelligrini, Zhengqi Lu, Mychica R. Jones, Paul Denver, Daniel Castro, Xuelin Gu et al. · 2020 · Frontiers in Immunology
48. Microglia in Alzheimer's Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis
    McFarland, Karen N., Chakrabarty, Paramita · 2022 · Neurotherapeutics
49. Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
    Barbara Vuić, Tina Milos, Lucija Tudor, Marcela Konjevod, Matea Nikolac Perković, Maja Jazvinšćak Jembrek, Gordana Nedić Erjavec, Dubravka Švob Štrac · 2022 · Biomedicines
50. Neuroprotective effects of the anticancer drug NVP-BEZ235 (dactolisib) on amyloid-β 1–42 induced neurotoxicity and memory impairment
    Paula Maria Quaglio Bellozi, Isabel Vieira de Assis Lima, Juliana G. Doria, Érica Leandro Marciano Vieira, Alline Cristina Campos, Eduardo Candelario‐Jalil, Helton José Reis, Antônio Lúcio Teixeira, Fabiola Mara Ribeiro, Antônio Carlos Pinheiro de Oliveira · 2016 · Scientific Reports
51. Inhibition of A1 Astrocytes and Activation of A2 Astrocytes for the Treatment of Spinal Cord Injury
    Jingxuan Wang, Cai Cheng, Zhongbing Liu, Yan Lin, Lingling Yang, Zijun Zhang, Xiaoduan Sun, Meiling Zhou, Pei Jing, Zhirong Zhong · 2022 · Neurochemical Research
52. Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders
    Golde, Todd E. · 2019 · Neuron
53. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles
    Anurag Kumar Singh, Gaurav Mishra, Anand Maurya, Rajendra Awasthi, Komal Kumari, Abhimanyu Thakur, Arati Rai, Gopal Kumar Rai, Bhupesh Sharma, Giriraj Thirupathirao Kulkarni et al. · 2019 · Current Alzheimer Research
54. Targeting innate immunity to protect and cure Alzheimer’s disease: opportunities and pitfalls
    Giulia Cisbani, Serge Rivest · 2021 · Molecular Psychiatry
55. Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
    Takatori, Sho, Wang, Wenbo, Iguchi, Akihiro, Tomita, Taisuke · 2019 · Advances in Experimental Medicine and Biology
56. Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer’s Disease Neuropathology
    F. Kok, Suzanne van Leerdam, E. D. de Lange · 2022 · Journal of Alzheimer's Disease
57. Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer’s disease pathology in aged squirrel monkeys
    Patel, Akash G, Nehete, Pramod N, Krivoshik, Sara R, Pei, Xuewei, Cho, Elizabeth L, Nehete, Bharti P, Ramani, Margish D, Shao, Yongzhao, Williams, Lawrence E, Wisniewski, Thomas et al. · 2021 · Brain
58. The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer’s Disease
    Thomas S. Webberley, Giulia Masetti, Ryan J. Bevan, Joshua Kerry-Smith, Alison A. Jack, Daryn R. Michael, Sophie Thomas, Maria Glymenaki, Jia Li, Julie A. K. McDonald et al. · 2022 · Frontiers in Neuroscience
59. LilrB3 is a putative cell surface receptor of APOE4
    Jiayao Zhou, Yumeng Wang, Gaoxingyu Huang, Min Yang, Yumin Zhu, Chen Jin, Dan Jing, Kai Ji, Yigong Shi · 2023 · Cell Research
60. Caspase-1 inhibition improves cognition without significantly altering amyloid and inflammation in aged Alzheimer disease mice
    Joseph Flores, Marie-Lyne Fillion, Andrea Claire LeBlanc · 2022 · Cell Death and Disease
61. Neuroinflammation — using big data to inform clinical practice
    Calliope Athena Dendrou, Gil McVean, Lars H. Fugger · 2016 · Nature Reviews Neurology
62. Neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices
    Haijun Wang, Yin Shen, Hao-Yu Chuang, Cheng‐Di Chiu, Youfan Ye, Lei Zhao · 2019 · Current Alzheimer Research
63. The risk of neurodevelopmental disorders at age 10 years associated with blood concentrations of interleukins 4 and 10 during the first postnatal month of children born extremely preterm
    Alan Leviton, Robert M. Joseph, Elizabeth N. Allred, Raina Nakova Fichorova, Thomas Michael O’Shea, Karl Kuban, Olaf Dammann · 2018 · Cytokine
64. Influenza vaccine combined with moderate-dose PD1 blockade reduces amyloid-β accumulation and improves cognition in APP/PS1 mice
    Zhiwei Xing, Zejie Zuo, Dandan Hu, Xiaona Zheng, Xiao Wang, Lifang Yuan, Lihua Zhou, Fangfang Qi, Zhibin Yao · 2020 · Brain Behavior and Immunity
65. Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization
    Maddalena Grieco, Maria Giovanna De Caris, Elisa Maggi, Federica Armeli, Roberto Coccurello, Tiziana Bisogno, Maria D’Erme, Mauro Maccarrone, Patrizia Mancini, Rita Businaro · 2021 · International Journal of Molecular Sciences
66. IKK2/NF-κB Activation in Astrocytes Reduces amyloid β Deposition: A Process Associated with Specific Microglia Polarization
    Shu Yang, A. Magnutzki, Najwa Ouali Alami, M. Lattke, T. Hein, Judith S. Scheller, Carsten Kröger, F. Oswald, D. Yilmazer-Hanke, T. Wirth et al. · 2021 · Cells
67. Interleukin‐12/23 deficiency differentially affects pathology in male and female Alzheimer's disease‐like mice
    Pascale Eede, Juliane Obst, Eileen Benke, Genevieve Yvon‐Durocher, Bernhard Clemens Richard, Niclas Gimber, Jan Schmoranzer, Annett Böddrich, Erich E. Wanker, Stefan Prokop et al. · 2020 · EMBO Reports
68. Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
    Lucianne Dobson, Ulrike Träger, Ruth E. Farmer, Liat Hayardeny, Pippa S. Loupe, Michael R. Hayden, Sarah J. Tabrizi · 2016 · Journal of Neurochemistry
69. The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer’s disease
    Antero Salminen, Kai Kaarniranta, Anu Kauppinen · 2018 · Cellular and Molecular Life Sciences
70. The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease
    Cun‐Gen Ma, Yige Wu, Lijuan Song, Lijun Yin, Jun-Jun Yin, Qing Wang, Jiezhong Yu, Bao‐Guo Xiao · 2022 · Neural Regeneration Research
71. Interferon‐β regulates the production of IL‐10 by toll‐like receptor‐activated microglia
    Diogo Lobo‐Silva, Guilhermina M. Carriche, António G. Castro, Susana Roque, Margarida Saraiva · 2017 · Glia
72. Microglia in Alzheimer's Disease: A Role for Ion Channels
    Laura Thei, Jennifer L. Imm, Eleni Kaisis, Mark L. Dallas, Talitha L. Kerrigan · 2018 · Frontiers in Neuroscience
73. Type I interferon (IFN)-inducible Absent in Melanoma 2 proteins in neuroinflammation: implications for Alzheimer’s disease
    Divaker Choubey · 2019 · Journal of Neuroinflammation
74. A review of stem cell therapy: An emerging treatment for dementia in Alzheimer's and Parkinson's disease
    Aishwarya Umesh Pradhan, Olivier Uwishema, Helen N. Onyeaka, Irem Adanur, Burhan Dost · 2022 · Brain and Behavior
75. RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment
    Iliya M. Lefterov, Jonathan Schug, Anaïs Mounier, Kyong Nyon Nam, Nicholas Francis Fitz, Radosveta P. Koldamova · 2015 · Neurobiology of Disease
76. Identification of novel immune‐relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis
    Zhijie Han, Weiwei Xue, Lin Tao, Feng Zhu · 2018 · CNS Neuroscience & Therapeutics
77. The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention
    Sara Merlo, Simona Federica Spampinato, Grazia Ilaria Caruso, Maria Angela Sortino · 2020 · Current Neuropharmacology
78. p38α‐MAPK‐deficient myeloid cells ameliorate symptoms and pathology of APP ‐transgenic Alzheimer's disease mice
    Qinghua Luo, Laura Schnöder, Wenlin Hao, Kathrin Litzenburger, Yann Decker, Inge Tomic, Michael Dieter Menger, Klaus C Fassbender, Klaus C Fassbender · 2022 · Aging Cell
79. Role of microglia autophagy and mitophagy in age-related neurodegenerative diseases
    Mingkai Lin, Hongwen Yu, Qiuyan Xie, Zhiyun Xu, Pei Shang · 2023 · Frontiers in Aging Neuroscience
80. The emerging role of brain neuroinflammatory responses in Alzheimer’s disease
    Mandana AmeliMojarad, Melika AmeliMojarad, Xiaonan Cui · 2024 · Frontiers in Aging Neuroscience
81. Elevated expression of the retrotransposon LINE-1 drives Alzheimer’s disease-associated microglial dysfunction
    Nainika Roy, Imdadul Haq, Jason C. Ngo, David A. Bennett, Andrew F. Teich, Philip L. De Jager, Marta Olah, Falak Sher · 2024 · Acta Neuropathologica
82. Linking T cells to Alzheimer's disease: from neurodegeneration to neurorepair
    Karen Jane Bryson, Marina A. Lynch · 2015 · Current Opinion in Pharmacology
83. Interleukin 10 Restores Lipopolysaccharide-Induced Alterations in Synaptic Plasticity Probed by Repetitive Magnetic Stimulation
    Maximilian Lenz, Amelie Eichler, Pia Kruse, Andreas Strehl, Silvia Rodriguez-Rozada, Itamar Goren, Nir Yogev, Stefan Frank, Ari Waisman, Thomas Deller et al. · 2020 · Frontiers in Immunology
84. Entanglement of CCR5 and Alzheimer’s Disease
    Tianwen Li, Jianhong Zhu · 2019 · Frontiers in Aging Neuroscience
85. Inflammation in Alzheimer’s Disease: Do Sex and APOE Matter?
    Paula Duarte‐Guterman, on behalf of the Alzheimer’s Disease Neuroimaging Initiative, Arianne Albert, Amy M. Inkster, Cindy K. Barha, Liisa A.M. Galea · 2020 · Journal of Alzheimer s Disease
86. Chronic IL-10 overproduction disrupts microglia-neuron dialogue similar to aging, resulting in impaired hippocampal neurogenesis and spatial memory
    Paula Sanchez-Molina, Beatriz Almolda, Lydia Giménez‐Llort, Berta González, Bernardo Castellano · 2022 · Brain Behavior and Immunity
87. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort
    Steve Pedrini, Veer Bala Gupta, Eugene Hone, James D. Doecke, Sid E. O’Bryant, IAN R. JAMES, Ashley Ian Bush, Christopher Cleon Rowe, Victor L. Villemagne, David J. Ames et al. · 2017 · Scientific Reports
88. The role of meningeal populations of type II innate lymphoid cells in modulating neuroinflammation in neurodegenerative diseases
    Sherry Sin-Hang Yeung, Janice Yuen Shan Ho, Raymond Chuen‐Chung Chang · 2021 · Experimental & Molecular Medicine
89. Association of anti-inflammatory cytokine IL10 polymorphisms with motoric cognitive risk syndrome in an Ashkenazi Jewish population
    Sanish Sathyan, Nir Barzilai, Gil Atzmon, Sofiya Milman, Emmeline I. Ayers, Joe Verghese · 2017 · Neurobiology of Aging
90. Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice
    Hyeon Joo Ham, Sang‐Bae Han, Jaesuk Yun, In Jun Yeo, Young Wan Ham, Se Hyun Kim, Pil‐Hoon Park, Dong‐Young Choi, Jin Tae Hong · 2019 · Translational Neurodegeneration
91. Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model
    Yiling Liu, Wei-Ting Chen, Yu-Yi Lin, Po-Hung Lu, Shie-Liang Edmond Hsieh, Irene Han-Juo Cheng · 2017 · Molecular Neurodegeneration
92. Microglial immunometabolism endophenotypes contribute to sex difference in Alzheimer's disease
    Yuan Hou, Jessica Caldwell, Justin Durla Lathia, James B. Leverenz, Andrew A. Pieper, Jeffrey L. Cummings, Feixiong Cheng · 2023 · Alzheimer s & Dementia
93. Neuro-regeneration Therapeutic for Alzheimer’s Dementia: Perspectives on Neurotrophic Activity
    Miao‐Kun Sun, Daniel L. Alkon · 2019 · Trends in Pharmacological Sciences
94. Dietary cis-9, trans-11-conjugated linoleic acid reduces amyloid β-protein accumulation and upregulates anti-inflammatory cytokines in an Alzheimer’s disease mouse model
    Yu Fujita, Kuniyuki Kano, Shigenobu Kishino, Toshihiro Nagao, Xuefeng Shen, Chiharu Sato, Hatsune Hatakeyama, Yume Ota, Sho Niibori, Ayako Nomura et al. · 2021 · Scientific Reports
95. Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimers Disease
    Tomone Nagae, Kiho Araki · 2016 · Journal of Clinical & Cellular Immunology
96. The Microglial Response to Neurodegenerative Disease
    Wilbur M. Song, Marco Colonna · 2018 · Advances in immunology
97. Cognitive resilience in Alzheimer’s disease: Mechanism and potential clinical intervention
    Bin Jia, Yun Xu, Xiaolei Zhu · 2025 · Ageing Research Reviews
98. Machine learning-assisted design of immunomodulatory lipid nanoparticles for delivery of mRNA to repolarize hyperactivated microglia
    Mehrnoosh Rafiei, Akbar Shojaei, Ying Chau · 2025 · Drug Delivery
99. Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets
    Francis J. Herman, Sherry J. Simkovic, Giulio Maria Pasinetti · 2019 · British Journal of Pharmacology
100. Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
     Tamàs Fülöp, Shreyansh Tripathi, Serafim Rodrigues, Mathieu Desroches, Ton Bunt, Arnold R. Eiser, Francois Bernier, Pascale B. Beauregard, Annelise E. Barron, Abdelouahed Khalil et al. · 2021 · Neuropsychiatric Disease and Treatment